J. Robert Dorkin

14.8k total citations · 6 hit papers
20 papers, 7.8k citations indexed

About

J. Robert Dorkin is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, J. Robert Dorkin has authored 20 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Genetics. Recurrent topics in J. Robert Dorkin's work include RNA Interference and Gene Delivery (19 papers), Advanced biosensing and bioanalysis techniques (15 papers) and MicroRNA in disease regulation (6 papers). J. Robert Dorkin is often cited by papers focused on RNA Interference and Gene Delivery (19 papers), Advanced biosensing and bioanalysis techniques (15 papers) and MicroRNA in disease regulation (6 papers). J. Robert Dorkin collaborates with scholars based in United States, Israel and Switzerland. J. Robert Dorkin's co-authors include Daniel G. Anderson, Arturo J. Vegas, Rosemary Kanasty, Ahmed A. Eltoukhy, Hao Yin, Róbert Langer, Owen S. Fenton, Frank DeRosa, Michael W. Heartlein and Kevin Kauffman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

J. Robert Dorkin

20 papers receiving 7.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Non-viral vectors for gene-based therapy

2014 2.6k citations Hao Yin, Rosemary Kanasty et al. Nature Reviews Genetics profile →
Delivery materials for siRNA therapeutics

2013 1.5k citations Rosemary Kanasty, J. Robert Dorkin et al. Nature Materials profile →
Lipid-like materials for low-dose, in vivo gene silencing

2010 792 citations Kevin T. Love, Kerry P. Mahon et al. Proceedings of the National Academy of Sciences profile →
Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs

2015 611 citations Kevin Kauffman, J. Robert Dorkin et al. Nano Letters profile →
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy

2016 582 citations Matthias A. Oberli, Andreas M. Reichmuth et al. Nano Letters profile →
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity

2014 496 citations Kathryn A. Whitehead, J. Robert Dorkin et al. Nature Communications profile →

Peers

Countries citing papers authored by J. Robert Dorkin

Since Specialization

Citations

This map shows the geographic impact of J. Robert Dorkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Robert Dorkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Robert Dorkin more than expected).

Fields of papers citing papers by J. Robert Dorkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Robert Dorkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Robert Dorkin. The network helps show where J. Robert Dorkin may publish in the future.

Co-authorship network of co-authors of J. Robert Dorkin

This figure shows the co-authorship network connecting the top 25 collaborators of J. Robert Dorkin. A scholar is included among the top collaborators of J. Robert Dorkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Robert Dorkin. J. Robert Dorkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression in vitro and in vivo 2023 ·Molecular Therapy — Nucleic Acids ·Elena M. Smekalova, María Guadalupe Martínez, Emmanuel Combe, Anuj Kumar, (unknown), Dominique Leboeuf, Chao‐Ying Chen, J. Robert Dorkin, (unknown), (unknown), Lauren Young, Luis Barrera, Michael S. Packer, Giuseppe Ciaramella, Barbara Testoni, Francine M. Gregoire, Fabien Zoulim	18
2	Rapid, Single-Cell Analysis and Discovery of Vectored mRNA Transfection In Vivo with a loxP-Flanked tdTomato Reporter Mouse 2017 ·Molecular Therapy — Nucleic Acids ·Kevin Kauffman, Matthias A. Oberli, J. Robert Dorkin, (unknown), James C. Kaczmarek, (unknown), Jeff Wyckoff, Róbert Langer, Ana Jaklenec, Daniel G. Anderson	78
3	Synthesis and Biological Evaluation of Ionizable Lipid Materials for the In Vivo Delivery of Messenger RNA to B Lymphocytes 2017 ·Advanced Materials ·Owen S. Fenton, Kevin Kauffman, James C. Kaczmarek, Rebecca L. McClellan, Siddharth Jhunjhunwala, Mark W. Tibbitt, (unknown), Eric A. Appel, J. Robert Dorkin, Faryal F. Mir, Jung Hoon Yang, Matthias A. Oberli, Michael W. Heartlein, Frank DeRosa, Róbert Langer, Daniel G. Anderson	243
4	Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system 2016 ·Nature ·Frank DeRosa, Braydon C. Guild, Shrirang Karve, (unknown), (unknown), Barak Yahalom, Michael W. Heartlein, Kerry R. Love, J. Robert Dorkin, Kevin Kauffman, Daniel G. Anderson	1
5	Poly(glycoamidoamine) brush nanomaterials for systemic siRNA delivery in vivo 2016 ·Biomaterials Science ·Xiongfei Luo, (unknown), J. Robert Dorkin, Omid Veiseh, Philip Chang, Inbal Abutbul‐Ionita, Dganit Danino, Róbert Langer, Daniel G. Anderson, Yizhou Dong	15
6	Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery 2016 ·Advanced Materials ·Owen S. Fenton, Kevin Kauffman, Rebecca L. McClellan, Eric A. Appel, J. Robert Dorkin, Mark W. Tibbitt, Michael W. Heartlein, Frank DeRosa, Róbert Langer, Daniel G. Anderson	199
7	Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system 2016 ·Gene Therapy ·Frank DeRosa, Braydon C. Guild, Shrirang Karve, (unknown), Kevin T. Love, J. Robert Dorkin, Kevin Kauffman, (unknown), Barak Yahalom, Daniel G. Anderson, Michael W. Heartlein	138
8	Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo 2016 ·Nano Letters ·Yizhou Dong, J. Robert Dorkin, Weiheng Wang, Philip Chang, Matthew J. Webber, Benjamin C. Tang, (unknown), Inbal Abutbul‐Ionita, Dganit Danino, Frank DeRosa, Michael W. Heartlein, Róbert Langer, Daniel G. Anderson	97
9	Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy breakdown → 2016 ·Nano Letters ·Matthias A. Oberli, Andreas M. Reichmuth, J. Robert Dorkin, Michael J. Mitchell, Owen S. Fenton, Ana Jaklenec, Daniel G. Anderson, Róbert Langer, Daniel Blankschtein	582
10	Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs breakdown → 2015 ·Nano Letters ·Kevin Kauffman, J. Robert Dorkin, Jung Hoon Yang, Michael W. Heartlein, Frank DeRosa, Faryal F. Mir, Owen S. Fenton, Daniel G. Anderson	611
11	Non-viral vectors for gene-based therapy breakdown → 2014 ·Nature Reviews Genetics ·Hao Yin, Rosemary Kanasty, Ahmed A. Eltoukhy, Arturo J. Vegas, J. Robert Dorkin, Daniel G. Anderson	2560
12	Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity breakdown → 2014 ·Nature Communications ·Kathryn A. Whitehead, J. Robert Dorkin, Arturo J. Vegas, Philip Chang, Omid Veiseh, J. Matthews, Owen S. Fenton, Yunlong Zhang, Karsten Olejnik, Volkan Yesilyurt, Delai Chen, Scott Barros, Boris Klebanov, Tatiana I. Novobrantseva, Róbert Langer, Daniel G. Anderson	496
13	Lipid‐Like Nanomaterials for Simultaneous Gene Expression and Silencing In Vivo 2014 ·Advanced Healthcare Materials ·Yizhou Dong, Ahmed A. Eltoukhy, Christopher A. Alabi, Omar F. Khan, Omid Veiseh, J. Robert Dorkin, Sasilada Sirirungruang, Hao Yin, Benjamin C. Tang, Jeisa M. Pelet, Delai Chen, Zhen Gu, Yuan Xue, Róbert Langer, Daniel G. Anderson	52
14	Delivery materials for siRNA therapeutics breakdown → 2013 ·Nature Materials ·Rosemary Kanasty, J. Robert Dorkin, Arturo J. Vegas, Daniel G. Anderson	1505
15	Delivery materials for siRNA therapeutics. Nat Mater 2013 ·Rosemary Kanasty, J. Robert Dorkin, Arturo J. Vegas, (unknown)	21
16	In Vitro-In Vivo Translation of Lipid Nanoparticles for Hepatocellular siRNA Delivery 2012 ·PMC ·Kathryn A. Whitehead, J. Matthews, Philip Chang, (unknown), J. Robert Dorkin, Mariano Severgnini, Daniel G. Anderson	8
17	In Vitro–In Vivo Translation of Lipid Nanoparticles for Hepatocellular siRNA Delivery 2012 ·ACS Nano ·Kathryn A. Whitehead, J. Matthews, Philip Chang, (unknown), J. Robert Dorkin, Mariano Severgnini, Daniel G. Anderson	113
18	Lipid-like materials for low-dose, in vivo gene silencing breakdown → 2010 ·Proceedings of the National Academy of Sciences ·Kevin T. Love, Kerry P. Mahon, Christopher G. Levins, Kathryn A. Whitehead, William Querbes, J. Robert Dorkin, June Qin, William Cantley, Liu Liang Qin, Timothy Racie, Maria Frank-Kamenetsky, (unknown), Rene Alvarez, Dinah W.Y. Sah, Antonin de Fougerolles, Kevin Fitzgerald, Victor Koteliansky, Akin Akinc, Róbert Langer, Daniel G. Anderson	792
19	Development of Lipidoid–siRNA Formulations for Systemic Delivery to the Liver 2009 ·Molecular Therapy ·Akin Akinc, Michael S. Goldberg, June Qin, J. Robert Dorkin, Christina Gamba‐Vitalo, Martin A. Maier, K. N. Jayaprakash, Muthusamy Jayaraman, Kallanthottathil G. Rajeev, Muthiah Manoharan, Victor Koteliansky, Ingo Röhl, Elizaveta S. Leshchiner, Róbert Langer, Daniel G. Anderson	283
20	Assessing siRNA Pharmacodynamics in a Luciferase-expressing Mouse 2008 ·Molecular Therapy ·Robert Svensson, (unknown), Zuhair K. Ballas, J. Robert Dorkin, Michael S. Goldberg, Akin Akinc, Róbert Langer, Daniel G. Anderson, David Bumcrot, Michael D. Henry	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact